Management of Chemotherapy-Induced Nausea & Vomiting

EP. 1: Why Practitioners Should Not Overlook CINV

July 26th 2016

EP. 2: Understanding Chemotherapy-Induced Nausea and Vomiting

July 26th 2016

EP. 3: CINV: Who Is at Risk?

July 26th 2016

EP. 4: Patient Assessment Tools for CINV

July 26th 2016

EP. 5: Optimal Use of 5-HT3 Antagonists in CINV

July 26th 2016

EP. 6: Managing Side Effects with Antiemetics

July 26th 2016

EP. 7: CINV: The Role of NK1 Receptor Antagonists

July 26th 2016

EP. 8: CINV: Newer Options for Prophylaxis and Treatment

July 26th 2016

EP. 9: Understanding the Guidelines for Anti-Emetics in CINV

July 26th 2016

EP. 10: Emesis Potential of Newer Anti-Cancer Therapies

July 26th 2016

EP. 11: Unmet Needs in CINV Treatment

July 26th 2016

EP. 12: Options in Breakthrough Nausea and Vomiting

July 26th 2016

EP. 13: Emerging Approaches in CINV

July 26th 2016

EP. 14: Optimizing Care to Avoid CINV

July 26th 2016

x